Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$161.52+0.73 (+0.45%)
Close on Nov 2, 2026Market cap $308.21BP/E 22.6Yield –
Novartis Interest Paid: -$546M in Q3 2026, up 88.3% from a year earlier. That is the lowest of the 36 quarters on record here.
Latest, Q3 2026
-546
Period ended Sep 30, 2026
Change on a year earlier
+88.3%
-290 in Q3 2025
History
36 quarters
Since Q4 2017
Sources
32
Documents cited below
Where the Q3 2026 figure comes from
“|| Interest paid | – 546 | – 290”
Source: Novartis Form 6-K (0001114448-26-000014) ↗
Reported in Form 6-K.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Novartis Interest Paid ($M), quarterly Q4 2017–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-cf-interest-paid
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.